John Anderson

7.3k total citations
147 papers, 4.3k citations indexed

About

John Anderson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, John Anderson has authored 147 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 46 papers in Oncology and 40 papers in Immunology. Recurrent topics in John Anderson's work include Neuroblastoma Research and Treatments (36 papers), CAR-T cell therapy research (31 papers) and Immune Cell Function and Interaction (28 papers). John Anderson is often cited by papers focused on Neuroblastoma Research and Treatments (36 papers), CAR-T cell therapy research (31 papers) and Immune Cell Function and Interaction (28 papers). John Anderson collaborates with scholars based in United Kingdom, United States and India. John Anderson's co-authors include Kathy Pritchard‐Jones, Jonathan Fisher, Janet Shipley, Neil J. Sebire, Kenth Gustafsson, Donald Ogilvie, Nigel J. Jones, Bryan Sykes, B P Wordsworth and Mengyong Yan and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

John Anderson

141 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Anderson United Kingdom 36 1.6k 1.4k 1.1k 1.0k 613 147 4.3k
Philippe Rochaix France 37 1.9k 1.2× 1.3k 0.9× 1.0k 0.9× 593 0.6× 402 0.7× 96 4.0k
Thomas Filleron France 33 2.1k 1.3× 1.1k 0.8× 958 0.8× 1.4k 1.4× 283 0.5× 222 4.9k
Leonhard Müllauer Austria 39 1.3k 0.8× 1.8k 1.3× 1.2k 1.0× 592 0.6× 448 0.7× 198 5.3k
Letterio S. Politi Italy 31 1.3k 0.8× 1.7k 1.2× 1.1k 0.9× 548 0.5× 890 1.5× 121 5.1k
Stephan D. Voss United States 46 1.7k 1.1× 2.1k 1.4× 1.2k 1.1× 1.2k 1.2× 1.7k 2.8× 173 6.8k
Giordano Nicoletti Italy 41 1.7k 1.0× 2.2k 1.6× 1.5k 1.3× 1.3k 1.3× 182 0.3× 140 4.9k
Daisuke Nonaka United States 35 1.7k 1.1× 1.6k 1.1× 373 0.3× 1.1k 1.1× 469 0.8× 101 4.5k
Charlotte M. Niemeyer Germany 54 1.6k 1.0× 4.1k 2.9× 2.1k 1.8× 887 0.9× 497 0.8× 260 10.3k
Patricia J.T.A. Groenen Netherlands 38 1.0k 0.6× 2.0k 1.4× 395 0.3× 780 0.8× 242 0.4× 129 4.3k
Kai‐Ping Chang Taiwan 42 2.0k 1.2× 2.2k 1.6× 644 0.6× 948 0.9× 234 0.4× 270 6.8k

Countries citing papers authored by John Anderson

Since Specialization
Citations

This map shows the geographic impact of John Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Anderson more than expected).

Fields of papers citing papers by John Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Anderson. The network helps show where John Anderson may publish in the future.

Co-authorship network of co-authors of John Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of John Anderson. A scholar is included among the top collaborators of John Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Anderson. John Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fowler, Daniel, Colin Hutton, Jahangir Sufi, et al.. (2025). Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell–Mediated Immunomodulation. Cancer Research. 85(22). 4415–4432.
2.
Giuliani, Stefano, Irene Paraboschi, Angus McNair, et al.. (2024). Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors. Cancers. 16(5). 1045–1045. 9 indexed citations
3.
Unaka, Ndidi, Sarah Elaine Eaton, Andrew F. Beck, et al.. (2024). Development and launch of a regional learning network to improve physical and mental health outcomes. Learning Health Systems. 9(2). e10462–e10462. 2 indexed citations
4.
Vydra, Jan, et al.. (2023). A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 23(5). e232–e239. 22 indexed citations
5.
Barisa, Marta, Alice Piapi, Talia Gileadi, et al.. (2022). Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells. Cytotherapy. 25(1). 46–58. 13 indexed citations
6.
Anderson, John, Robbie G. Majzner, & Paul M. Sondel. (2022). Immunotherapy of Neuroblastoma: Facts and Hopes. Clinical Cancer Research. 28(15). 3196–3206. 58 indexed citations
7.
Meier, Stefanie L., Sandra Cantilena, Maria Victoria Niklison-Chirou, et al.. (2021). Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. Cell Death and Disease. 12(8). 785–785. 13 indexed citations
8.
Poon, Evon, Matthew Clarke, Neil P. Jerome, et al.. (2020). Noninvasive MRI Native T1 Mapping Detects Response to MYCN -targeted Therapies in the Th- MYCN Model of Neuroblastoma. Cancer Research. 80(16). 3424–3435. 21 indexed citations
9.
Sathianathen, Niranjan, Suprita Krishna, John Anderson, et al.. (2017). The current status of immunobased therapies for metastatic renal-cell carcinoma. ImmunoTargets and Therapy. Volume 6. 83–93. 13 indexed citations
10.
Morgenstern, Daniel A., Gulrukh Ahsan, Stuart J. Ings, et al.. (2016). Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes. British Journal of Haematology. 174(6). 942–951. 32 indexed citations
11.
Mussai, Francis, Sharon A. Egan, Stuart Hunter, et al.. (2015). Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. Cancer Research. 75(15). 3043–3053. 84 indexed citations
12.
Gilham, David E., John Anderson, John S. Bridgeman, et al.. (2015). Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015. Human Gene Therapy. 26(5). 276–285. 15 indexed citations
13.
Fisher, Jonathan, Mengyong Yan, Lisa Carter, et al.. (2014). Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells. Clinical Cancer Research. 20(22). 5720–5732. 88 indexed citations
14.
Morgenstern, Daniel A. & John Anderson. (2010). The immune response in paediatric cancer. UCL Discovery (University College London). 4(1). 2 indexed citations
15.
Himoudi, Nourredine, Mengyong Yan, Gerben Bouma, et al.. (2009). Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells. Cancer Research. 69(16). 6598–6606. 11 indexed citations
16.
Reusch, J.A., John Anderson, F. Ebrahimi, et al.. (2009). Simulated and Measured Electron Thermal Transport with Varying Stochasticity in the MST RFP. Bulletin of the American Physical Society. 51. 1 indexed citations
17.
Yan, Mengyong, Nourredine Himoudi, Martin Pulé, et al.. (2008). Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy. Cancer Research. 68(19). 8058–8065. 13 indexed citations
18.
Himoudi, Nourredine, et al.. (2008). Bone Marrow-Derived IFN-Producing Killer Dendritic Cells Account for the Tumoricidal Activity of Unpulsed Dendritic Cells. The Journal of Immunology. 181(9). 6654–6663. 18 indexed citations
19.
Anderson, John, et al.. (2006). Expression of ETV6‐NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma. Histopathology. 48(6). 748–753. 49 indexed citations
20.
Williamson, Daniel, et al.. (2006). The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas. Growth Factors. 24(3). 197–208. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026